Martijn G.H. van Oijen

Lanreotide Reduces the Volume of Polycystic Liver: A Randomized, Double-Blind, Placebo-Controlled Trial

Loes van Keimpema, Frederik Nevens, Ragna Vanslembrouck et al. · Gastroenterology · 2009 · 256 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease

Fiona D M van Schaik, Martijn G.H. van Oijen, Hugo M. Smeets et al. · Gut · 2011 · 144 citations

Life Sciences, Neurobiology, Neuroscience +17

Serological markers predict inflammatory bowel disease years before the diagnosis

Fiona D M van Schaik, Bas Oldenburg, Andrew Hart et al. · Gut · 2012 · 132 citations

Medicine, Clinical Sciences, Immunology +17

The long‐term outcome of patients with polycystic liver disease treated with lanreotide

Melissa Chrispijn, F. Nevens, Tom J.G. Gevers et al. · Alimentary Pharmacology & Therapeutics · 2011 · 96 citations · Full text

Medicine, Pharmacotherapy, Radiology +16

Non-adherence to Anti-TNF Therapy is Associated with Illness Perceptions and Clinical Outcomes in Outpatients with Inflammatory Bowel Disease: Results from a Prospective Multicentre Study

Mike van der Have, Bas Oldenburg, Ad A. Kaptein et al. · Journal of Crohn s and Colitis · 2016 · 92 citations · Full text

Pharmacy, Pharmacotherapy, Gastrointestinal Pharmacotherapy +14